AI Article Synopsis
- The FODMAP diet has been used for years as a treatment for irritable bowel syndrome (IBS), supported by scientific research that highlights its effectiveness and possible downsides.
- The diet has been refined into various forms, including a three-phase approach, a less restrictive FODMAP-gentle version, and a Mediterranean-style diet aimed at improving gut symptoms and overall health.
- New studies are exploring the FODMAP diet's effects on non-IBS groups, such as older adults with diarrhea and women with endometriosis, indicating promising areas for future research.
Article Abstract
The FODMAP diet has been a treatment of irritable bowel syndrome (IBS) for many years. Rigorous scientific evaluation and clinical application of the FODMAP diet have generated deep understanding regarding clinical efficacy, mechanisms of action, and potential adverse effects of this dietary approach. In turn, this knowledge has allowed fine-tuning of the diet to optimize treatment benefits and minimize risks, in the form of the traditional three-phase diet; the FODMAP-gentle approach, which is a less restrictive iteration; and a proposed FODMAP-modified, Mediterranean-style diet which endeavours to optimise both gastrointestinal symptoms and other health parameters. Furthermore, recognition that IBS-like symptoms feature in other conditions has seen the FODMAP diet tested in non-IBS populations, including in older adults with diarrhea and women with endometriosis. These areas represent new frontiers for the FODMAP diet and a space to watch as future research evaluates the validity of these novel clinical applications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103764 | PMC |
| http://dx.doi.org/10.1002/jgh3.13066 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relationship between SIBO and other bowel diseases and a common eating pattern for them. Part III.
Ann Agric Environ Med
September 2024
Higher School of Health Promotion, Kraków, Poland.
Article Synopsis
- The study explores the relationship between small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), and inflammatory bowel diseases (IBD), stressing the potential benefits of diet therapy.
- A literature review suggests that SIBO is commonly associated with IBS and shares symptoms like abdominal pain and bloating, implying potential overlaps between these conditions.
- Increasing evidence links SIBO with IBD, particularly in Crohn's disease, highlighting the need for comprehensive treatment approaches that combine medication, psychotherapy, probiotics, and tailored dietary plans.
Nutrition Interventions in the Treatment of Endometriosis: A Scoping Review.
J Hum Nutr Diet
February 2025
Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Background: Pain, poor quality of life (QOL) and gastrointestinal (GI) symptoms are commonly experienced by individuals with endometriosis. Although diet and nutrition supplements are frequently used to manage endometriosis-related symptoms, there is limited understanding of the breadth and quality of research in this field. Our aim was to undertake a scoping review of diet and nutrition supplement intervention studies in people with endometriosis, diagnosed by ultrasound or surgery.
View Article and Find Full Text PDFGluten-Free Diet for Fashion or Necessity? Review with New Speculations on Irritable Bowel Syndrome-like Disorders.
Nutrients
December 2024
Stella Maris S.T.P.-Food and Human Nutrition Unit, 00139 Rome, Italy.
Nowadays, the gluten-free diet (GFD) has become much more than the dietary treatment for celiac disease. Due to its presumed beneficial effects even in non-celiac subjects, it has become a new fashion statement and it is promoted by some healthcare professionals, social media and marketing strategists. On the other hand, regardless of a proper medical indication, a GFD may present side effects, such as poor palatability, high costs and socio-psychological adversities.
View Article and Find Full Text PDFFODMAP Diet in Celiac Disease and Gluten-Related Disorders.
Nutrients
December 2024
Digestive Endoscopy, ARNAS G. Brotzu, 09121 Cagliari, Italy.
Background: Individuals with celiac disease (CD) often report the persistence of gastrointestinal symptoms despite adherence to a gluten-free diet (GFD). A diet rich in fermentable oligo-, di-, and monosaccharides and polyols (FODMAPs) could cause symptoms in CD on a GFD, and conversely a low-FODMAP diet could positively influence the therapeutic management of CD and non-celiac gluten sensitivity (NCGS). The aim of this review was to explore the hypothetical impact of the FODMAD diet and the low-FODMAP diet (LFD) in CD and gluten-related disorders.
View Article and Find Full Text PDFNon-pharmaceutical treatments for irritable bowel syndrome.
BMJ
December 2024
Gentle GI, Houston, TX, USA.
Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction that impacts a significant portion of the population and is associated with substantial morbidity, reduced quality of life, and economic impact globally. The pathophysiology of IBS is complex and incompletely understood, and the heterogeneity of IBS is reflected in the variety of pharmaceutical and non-pharmaceutical therapies utilized for the management of IBS. Given limitations with pharmaceutical treatments, many patients with IBS seek non-pharmaceutical options.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!